Two things about lichen sclerosus are widely misunderstood, and both cause women to undertreat a condition that responds well to treatment.
One: the thinning of vulvar skin is caused by the disease, not by the steroid used to treat it. Almost every woman prescribed clobetasol worries about the opposite.
Two: staying on maintenance treatment is associated with lower cancer risk, not higher. The fear of the treatment is doing more damage than the treatment ever could.
This article is about living with it well.
In this article
- What it is
- Who gets it
- Why it is diagnosed so late
- The steroid myth, corrected
- The treatment that works
- Maintenance, and why it is not optional
- The cancer question, answered directly
- Daily care alongside treatment
- Frequently asked questions
What it is
An inflammatory skin condition characterised by intense vulvar itching. Skin becomes pale, white or shiny, thins in places and thickens in others, and can split, tear or bleed.
Without treatment it can cause scarring and irreversible anatomic changes, including narrowing of the anogenital area and loss of normal vulvar structure.
It is chronic rather than curable, and it is manageable. Those two facts sit together.
Who gets it
It most commonly affects two groups: prepubertal girls, and perimenopausal or postmenopausal women.
That second group is the reason it goes unrecognised so often, because it is exactly the population being told their symptoms are hormonal.
Genitourinary syndrome of menopause and lichen sclerosus are not the same condition, and a woman can have both at once. The distinction is covered in perimenopausal vulvar itching.
Why it is diagnosed so late
Years, commonly. The reasons are consistent.
Symptoms overlap with thrush, and many women self-treat with antifungals repeatedly. Repeated negative tests are the clue.
Age assumptions. In the peri and postmenopausal group, itching is attributed to hormones.
Nobody looks. Most women have never examined their own vulva, so pale patches and texture changes go unnoticed until symptoms are severe.
It is not raised. Genital itching is embarrassing to describe.
What to look for: white, pale or shiny patches, skin that looks crinkled or thickened, splitting or fissuring, itching intense enough to wake you, pain with sex, and changes in the shape of the vulva over time.
Any of those warrants an examination. Classic presentations without erosion or thickened tissue may not need a biopsy, but persistent pain, firm nodules or any suspicion of malignancy does.
The steroid myth, corrected
The most consequential misunderstanding in this condition.
Women are prescribed a potent topical steroid, read that steroids thin skin, look at their already thinning vulvar skin, and use it sparingly or stop. That decision is understandable and it is backwards.
Vulvar thinning in lichen sclerosus results from the underlying condition rather than from steroid use. The disease causes the thinning. The treatment controls the disease.
Because of this, mid-potency topical steroids can be safely continued for long-term maintenance.
Using it as prescribed is the correct action. Using it sparingly out of fear is how scarring and irreversible change happen.
The treatment that works
Clobetasol propionate 0.05% ointment is universally recommended as first-line, and depending on clinical signs, patients may require daily topical treatment for twelve weeks.
The usual shape of it: an induction phase of daily application, then reduction to a maintenance frequency. Ointment rather than cream, because it is better tolerated on this tissue.
A very small amount goes a long way. Your clinician should show you exactly how much and where. If they did not, ask, because application technique is where most treatment failures come from.
Expect improvement over weeks, not days. Itching usually settles first. Skin appearance takes longer.
Maintenance, and why it is not optional
The part most likely to be abandoned once symptoms settle.
After initial symptoms and clinical signs are controlled, indefinite maintenance therapy with topical steroids prevents squamous cell carcinoma and irreversible anatomic changes.
Read that again. Maintenance is not about comfort. It prevents structural damage and it prevents cancer.
Stopping when it feels better is the single most common mistake, and the consequences accumulate quietly over years rather than announcing themselves.
Stay under review. Regular examination matters, and palpation remains an essential part of vulvar examination to detect abnormalities that are not visible.
The cancer question, answered directly
Because everyone searches it and most articles are vague.
There is an estimated 5% risk of progression to squamous cell carcinoma. That is real and it is why monitoring matters.
The vast majority of women with lichen sclerosus do not go on to develop cancer. 5% means 95% do not.
And treatment reduces the risk. Clobetasol use has been associated with a reduced risk of malignancy at two years following diagnosis, and indefinite maintenance is described as preventing squamous cell carcinoma.
So the correct response to the cancer risk is treatment and monitoring, not avoidance of the treatment. The women at highest risk are the undiagnosed and the undertreated.
Report promptly: any new lump, thickened area, ulcer or sore that does not heal, persistent pain in one spot, or bleeding. Those warrant tissue sampling rather than reassurance.
Daily care alongside treatment
To be explicit before anything else in this section: none of this treats lichen sclerosus. Treatment is the prescribed steroid. What follows reduces irritation on top of the condition.
Stop soap entirely. Alkaline products on skin that is already fragile add irritation to a condition. Water, or something formulated near the pH of this tissue. Reasoning in why soap is wrong for vulvar skin.
Unscented detergent, no fabric softener, cotton underwear.
An emollient between steroid applications. Many women with lichen sclerosus use a bland moisturiser alongside prescribed treatment to reduce friction and dryness. An external balm formulated for vulvar skin can serve that role, applied to comfort. It is comfort care alongside treatment, never a substitute for it, and it does not affect the disease process or the cancer risk.
Lubricant for sex. Splitting and fissuring make friction genuinely damaging. Use generously.
Look at yourself monthly with a mirror, and photograph if it helps you track change.
Find a specialist. A vulval clinic or a dermatologist with vulvar experience is worth asking for. This condition is managed better by people who see it often.
Frequently asked questions
Does lichen sclerosus go away?
It is chronic rather than curable, and it is manageable. Treatment controls symptoms and, importantly, indefinite maintenance therapy prevents irreversible anatomic changes and reduces cancer risk. Well-managed lichen sclerosus can be close to symptom-free.
Will the steroid thin my skin further?
No, and this is the most important correction to make. Vulvar thinning in lichen sclerosus results from the underlying condition rather than from steroid use, which is why mid-potency steroids can be safely continued long term for maintenance. Using treatment sparingly out of fear is what allows the disease to cause damage.
Does lichen sclerosus cause cancer?
There is an estimated 5% risk of progression to squamous cell carcinoma, so monitoring matters. The vast majority do not develop cancer, and topical steroid treatment has been associated with reduced malignancy risk. The risk sits with undiagnosed and undertreated disease.
Can I stop treatment once symptoms improve?
Not without discussing it. After control is achieved, indefinite maintenance is what prevents squamous cell carcinoma and irreversible anatomic change. Stopping when it feels better is the most common mistake and the damage accumulates silently.
Is lichen sclerosus caused by menopause?
No, though it most commonly affects prepubertal girls and perimenopausal or postmenopausal women. It is a distinct inflammatory skin condition, it can occur alongside genitourinary syndrome of menopause, and current guidance recommends against topical estrogen as a treatment for lichen sclerosus itself.
Can a balm help lichen sclerosus?
It can improve comfort by reducing dryness and friction alongside prescribed treatment, and it does nothing to the disease process or the cancer risk. It is not a treatment and should never replace a prescribed steroid.
Sources
- Lichen sclerosus treatment and management: Medscape
- Vulvar squamous cell carcinoma and why lichen sclerosus is monitored: PMC4564427
- Topical therapy and vulvar malignancy risk in lichen sclerosus, propensity-matched study: ScienceDirect
- Vulvar lichen sclerosus in perimenopausal and postmenopausal women: PMC11006835
- Characterisation of patients with vulvar lichen sclerosus and association with vulvar carcinoma: PMC10147807